Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$73.5M |
| 2 |
Yum! Brands
YUM
|
+$68.2M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$65.7M |
| 4 |
Entergy
ETR
|
+$47.4M |
| 5 |
Meta Platforms (Facebook)
META
|
+$44.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$131M |
| 2 |
DuPont de Nemours
DD
|
+$73.4M |
| 3 |
FRX
FOREST LABORATORIES INC
FRX
|
+$54.3M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$52.1M |
| 5 |
Edison International
EIX
|
+$50.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.94% |
| 2 | Financials | 13.88% |
| 3 | Technology | 13.41% |
| 4 | Industrials | 10.96% |
| 5 | Energy | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
GoPro
GPRO
$114M
| $1.64M | ﹤0.01% |
+17,458
| New | +$892K |
|
2077
Fabrinet
FN
$18.8B
| $1.62M | ﹤0.01% |
111,044
+23,890
| +27% | +$417K |
|
|
SASR
2078
DELISTED
Sandy Spring Bancorp Inc
SASR
| $1.62M | ﹤0.01% |
70,812
+1,463
| +2% | +$34.9K |
|
|
INFI
2079
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.62M | ﹤0.01% |
120,589
-4,893
| -4% | -$58.3K |
|
2080
Forestar Group
FOR
$1.48B
| $1.61M | ﹤0.01% |
91,050
+2,141
| +2% | +$41K |
|
|
EPIQ
2081
DELISTED
EPIQ SYSTEMS INC
EPIQ
| $1.61M | ﹤0.01% |
91,578
-20,306
| -18% | -$302K |
|
2082
Zumiez
ZUMZ
$322M
| $1.61M | ﹤0.01% |
57,215
-2,274
| -4% | -$66.8K |
|
|
TRST
2083
Trustco Bank Corp NY
TRST
$953M
| $1.61M | ﹤0.01% |
49,863
+4,196
| +9% | +$142K |
|
|
DMND
2084
DELISTED
DIAMOND FOODS, INC.
DMND
| $1.6M | ﹤0.01% |
55,944
+1,168
| +2% | +$32.2K |
|
2085
Tompkins Financial
TMP
$1.43B
| $1.6M | ﹤0.01% |
36,287
+3,003
| +9% | +$137K |
|
2086
Southside Bancshares
SBSI
$965M
| $1.6M | ﹤0.01% |
54,342
+1,095
| +2% | +$30K |
|
2087
Precigen
PGEN
$2.46B
| $1.59M | ﹤0.01% |
89,771
+20,216
| +29% | +$413K |
|
2088
Rayonier Advanced Materials
RYAM
$590M
| $1.59M | ﹤0.01% |
+48,343
| New | +$1.7M |
|
|
PHIIK
2089
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
| $1.59M | ﹤0.01% |
38,602
+6,114
| +19% | +$258K |
|
|
RDEN
2090
DELISTED
ELIZABETH ARDEN INC
RDEN
| $1.59M | ﹤0.01% |
94,847
+5,539
| +6% | +$105K |
|
2091
Blackstone Mortgage Trust
BXMT
$2.47B
| $1.59M | ﹤0.01% |
58,538
+2,941
| +5% | +$84K |
|
|
RAS
2092
DELISTED
RAIT Financial Trust
RAS
| $1.58M | ﹤0.01% |
213,160
+4,489
| +2% | +$35.4K |
|
|
LABL
2093
DELISTED
Multi-Color Corp
LABL
| $1.58M | ﹤0.01% |
34,797
+714
| +2% | +$31K |
|
|
NSM
2094
DELISTED
Nationstar Mortgage Holdings
NSM
| $1.58M | ﹤0.01% |
46,148
+8,669
| +23% | +$287K |
|
2095
Biglari Holdings Class B
BH
$1.2B
| $1.57M | ﹤0.01% |
6,938
+841
| +14% | +$210K |
|
|
BRKL
2096
DELISTED
Brookline Bancorp
BRKL
| $1.56M | ﹤0.01% |
182,992
+3,893
| +2% | +$35.2K |
|
|
BSFT
2097
DELISTED
BroadSoft, Inc.
BSFT
| $1.56M | ﹤0.01% |
74,323
-2,774
| -4% | -$65.5K |
|
2098
Agios Pharmaceuticals
AGIO
$1.95B
| $1.56M | ﹤0.01% |
25,399
+301
| +1% | +$13K |
|
|
RENT
2099
DELISTED
RENTRAK CORP
RENT
| $1.56M | ﹤0.01% |
25,543
-1,268
| -5% | -$66.2K |
|
|
GHDX
2100
DELISTED
Genomic Health, Inc.
GHDX
| $1.56M | ﹤0.01% |
54,938
+1,106
| +2% | +$30.8K |
|
Similar funds
Charles Schwab's Q3 2014 Portfolio in Review
As of Q3 2014, Charles Schwab held 3,120 positions worth $60.8B, up 2.2% from $59.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.5%. Charles Schwab opened 31 new positions and exited 48, leaving the 3,120-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- Charles Schwab's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 589,874 shares worth $22M.
- Charles Schwab added most to Microsoft in Q3 2014, an estimated $73.5M increase.
- Charles Schwab's biggest Q3 2014 reduction was Medtronic, cutting an estimated $131M.
- Charles Schwab fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $54.3M.
- Charles Schwab's ten largest holdings make up 14% of its $60.8B portfolio in Q3 2014.
- Charles Schwab opened 31 new positions and closed 48 in Q3 2014.
- Charles Schwab's portfolio value rose 2.2% quarter-over-quarter to $60.8B.
Based on Charles Schwab's 13F filing for Q3 2014, filed 10 Nov 2014.